These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

206 related items for PubMed ID: 9396739

  • 1. Role of membrane-anchored heparin-binding epidermal growth factor-like growth factor and CD9 on macrophages.
    Ouchi N, Kihara S, Yamashita S, Higashiyama S, Nakagawa T, Shimomura I, Funahashi T, Kameda-Takemura K, Kawata S, Taniguchi N, Matsuzawa Y.
    Biochem J; 1997 Dec 15; 328 ( Pt 3)(Pt 3):923-8. PubMed ID: 9396739
    [Abstract] [Full Text] [Related]

  • 2. Localization of CD9, an enhancer protein for proheparin-binding epidermal growth factor-like growth factor, in human atherosclerotic plaques: possible involvement of juxtacrine growth mechanism on smooth muscle cell proliferation.
    Nishida M, Miyagawa J, Yamashita S, Higashiyama S, Nakata A, Ouchi N, Tamura R, Yamamori K, Kihara S, Taniguchi N, Matsuzawa Y.
    Arterioscler Thromb Vasc Biol; 2000 May 15; 20(5):1236-43. PubMed ID: 10807738
    [Abstract] [Full Text] [Related]

  • 3. The membrane protein CD9/DRAP 27 potentiates the juxtacrine growth factor activity of the membrane-anchored heparin-binding EGF-like growth factor.
    Higashiyama S, Iwamoto R, Goishi K, Raab G, Taniguchi N, Klagsbrun M, Mekada E.
    J Cell Biol; 1995 Mar 15; 128(5):929-38. PubMed ID: 7876316
    [Abstract] [Full Text] [Related]

  • 4. Significance of the association between heparin-binding epidermal growth factor-like growth factor and CD9 in human gastric cancer.
    Murayama Y, Miyagawa J, Shinomura Y, Kanayama S, Isozaki K, Yamamori K, Mizuno H, Ishiguro S, Kiyohara T, Miyazaki Y, Taniguchi N, Higashiyama S, Matsuzawa Y.
    Int J Cancer; 2002 Apr 01; 98(4):505-13. PubMed ID: 11920609
    [Abstract] [Full Text] [Related]

  • 5. Coexpression of CD9 augments the ability of membrane-bound heparin-binding epidermal growth factor-like growth factor (proHB-EGF) to preserve renal epithelial cell viability.
    Takemura T, Hino S, Murata Y, Yanagida H, Okada M, Yoshioka K, Harris RC.
    Kidney Int; 1999 Jan 01; 55(1):71-81. PubMed ID: 9893115
    [Abstract] [Full Text] [Related]

  • 6. Importance of the major extracellular domain of CD9 and the epidermal growth factor (EGF)-like domain of heparin-binding EGF-like growth factor for up-regulation of binding and activity.
    Nakamura K, Mitamura T, Takahashi T, Kobayashi T, Mekada E.
    J Biol Chem; 2000 Jun 16; 275(24):18284-90. PubMed ID: 10749879
    [Abstract] [Full Text] [Related]

  • 7. Membrane-anchored heparin-binding EGF-like growth factor (HB-EGF) and diphtheria toxin receptor-associated protein (DRAP27)/CD9 form a complex with integrin alpha 3 beta 1 at cell-cell contact sites.
    Nakamura K, Iwamoto R, Mekada E.
    J Cell Biol; 1995 Jun 16; 129(6):1691-705. PubMed ID: 7790364
    [Abstract] [Full Text] [Related]

  • 8. Possible role of coexpression of CD9 with membrane-anchored heparin-binding EGF-like growth factor and amphiregulin in cultured human keratinocyte growth.
    Inui S, Higashiyama S, Hashimoto K, Higashiyama M, Yoshikawa K, Taniguchi N.
    J Cell Physiol; 1997 Jun 16; 171(3):291-8. PubMed ID: 9180898
    [Abstract] [Full Text] [Related]

  • 9. CD9 antigen interacts with heparin-binding EGF-like growth factor through its heparin-binding domain.
    Sakuma T, Higashiyama S, Hosoe S, Hayashi S, Taniguchi N.
    J Biochem; 1997 Aug 16; 122(2):474-80. PubMed ID: 9378729
    [Abstract] [Full Text] [Related]

  • 10. Heparin-binding epidermal growth factor-like growth factor regulates fibroblast growth factor-2 expression in aortic smooth muscle cells.
    Peifley KA, Alberts GF, Hsu DK, Feng SL, Winkles JA.
    Circ Res; 1996 Aug 16; 79(2):263-70. PubMed ID: 8756003
    [Abstract] [Full Text] [Related]

  • 11. Amino-terminal processing of cell surface heparin-binding epidermal growth factor-like growth factor up-regulates its juxtacrine but not its paracrine growth factor activity.
    Nakagawa T, Higashiyama S, Mitamura T, Mekada E, Taniguchi N.
    J Biol Chem; 1996 Nov 29; 271(48):30858-63. PubMed ID: 8940069
    [Abstract] [Full Text] [Related]

  • 12. Phorbol ester induces the rapid processing of cell surface heparin-binding EGF-like growth factor: conversion from juxtacrine to paracrine growth factor activity.
    Goishi K, Higashiyama S, Klagsbrun M, Nakano N, Umata T, Ishikawa M, Mekada E, Taniguchi N.
    Mol Biol Cell; 1995 Aug 29; 6(8):967-80. PubMed ID: 7579712
    [Abstract] [Full Text] [Related]

  • 13. Heparin-like molecules on the cell surface potentiate binding of diphtheria toxin to the diphtheria toxin receptor/membrane-anchored heparin-binding epidermal growth factor-like growth factor.
    Shishido Y, Sharma KD, Higashiyama S, Klagsbrun M, Mekada E.
    J Biol Chem; 1995 Dec 08; 270(49):29578-85. PubMed ID: 7494001
    [Abstract] [Full Text] [Related]

  • 14. Lysophosphatidylcholine upregulates the level of heparin-binding epidermal growth factor-like growth factor mRNA in human monocytes.
    Nakano T, Raines EW, Abraham JA, Klagsbrun M, Ross R.
    Proc Natl Acad Sci U S A; 1994 Feb 01; 91(3):1069-73. PubMed ID: 8302833
    [Abstract] [Full Text] [Related]

  • 15. Heparin-binding EGF-like growth factor: a juxtacrine growth factor.
    Iwamoto R, Mekada E.
    Cytokine Growth Factor Rev; 2000 Dec 01; 11(4):335-44. PubMed ID: 10959080
    [Abstract] [Full Text] [Related]

  • 16. Heparin-binding EGF-like growth factor in the human prostate: synthesis predominantly by interstitial and vascular smooth muscle cells and action as a carcinoma cell mitogen.
    Freeman MR, Paul S, Kaefer M, Ishikawa M, Adam RM, Renshaw AA, Elenius K, Klagsbrun M.
    J Cell Biochem; 1998 Mar 01; 68(3):328-38. PubMed ID: 9518259
    [Abstract] [Full Text] [Related]

  • 17. Detection and cellular localization of heparin-binding epidermal growth factor-like growth factor mRNA and protein in human atherosclerotic tissue.
    Reape TJ, Wilson VJ, Kanczler JM, Ward JP, Burnand KG, Thomas CR.
    J Mol Cell Cardiol; 1997 Jun 01; 29(6):1639-48. PubMed ID: 9220349
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.